{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T06:36:50Z","timestamp":1795243010671,"version":"4.10.3"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.vaccine.2025.127876","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T15:42:47Z","timestamp":1761234167000},"page":"127876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Science for vaccine policy: Independent review of the September 2025 ACIP processes, deliberations and votes"],"prefix":"10.1016","volume":"67","author":[{"given":"Edwin J.","family":"Asturias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte A.","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne A.","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane R.","family":"Zucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Y.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Keipp","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybil","family":"Cineas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Schechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mini","family":"Kamboj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanthia","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel T.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2025.127876_bb0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.vaccine.2014.09.043","article-title":"The history of the United States Advisory Committee on Immunization Practices (ACIP)","volume":"33","author":"Walton","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127876_bb0010","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.mayocp.2019.11.002","article-title":"Principles of vaccine licensure, approval, and recommendations for use","volume":"95","author":"Pickering","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127876_bb0015","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/jama.2025.10776","article-title":"Advisory Committee on Immunization Practices at a crossroads","volume":"334","author":"Asturias","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127876_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.r1992","article-title":"US vaccine committee changes MMR and hepatitis vaccine schedules amid criticism","volume":"390","author":"Tanne","year":"2025","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127876_bb0025","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.mayocp.2019.11.002","article-title":"Principles of vaccine licensure, approval, and recommendations for use","volume":"95","author":"Pickering","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"49","key":"10.1016\/j.vaccine.2025.127876_bb0030","doi-asserted-by":"crossref","first-page":"9171","DOI":"10.1016\/j.vaccine.2011.08.005","article-title":"ACIP evidence based recommendations work group (EBRWG). Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC)","volume":"29","author":"Ahmed","year":"2011","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2025.127876_bb0035","first-page":"327","article-title":"Centers for Disease Control and Prevention (CDC). New framework (GRADE) for development of evidence-based recommendations by the Advisory Committee on Immunization Practices","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127876_bb0040","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"45","key":"10.1016\/j.vaccine.2025.127876_bb0045","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.15585\/mmwr.mm6745a4","article-title":"ACIP evidence-based recommendations work group, ACIP evidence based recommendations work group. Updated framework for development of evidence-based recommendations by the Advisory Committee on Immunization Practices","volume":"67","author":"Lee","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127876_bb0050","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2025.11400","article-title":"The Advisory Committee on Immunization Practices-legal roles, challenges, and guardrails","volume":"334","author":"Daval","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127876_bb0055","doi-asserted-by":"crossref","DOI":"10.7326\/ANNALS-25-03101","article-title":"The U.S. Advisory Committee on Immunization Practices: public health in the crosshairs","author":"Goldman","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2025.127876_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(25)00212-7","article-title":"Medical societies unite against RFK Jr\u2019s COVID vaccine update","author":"Kirby","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2025.127876_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaf098","article-title":"The US Advisory Committee on Immunization Practices (ACIP): Trustworthy Travel Vaccine Guidance and Politics","author":"Chen","year":"2025","journal-title":"J Travel Med"},{"issue":"6753","key":"10.1016\/j.vaccine.2025.127876_bb0090","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.adz8347","article-title":"New vaccine panelists have published little on vaccines","volume":"388","author":"Enserink","year":"2025","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.vaccine.2025.127876_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.05.053","article-title":"Development of a maturity assessment tool to evaluate and strengthen National Immunization Technical Advisory Groups (NITAGs)","volume":"42","author":"Dryer","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127876_bb0105","unstructured":"National Immunization Technical Advisory Groups (NITAGs). Accessed October 9, 2025, 2025. https:\/\/www.who.int\/europe\/groups\/national-immunization-technical-advisory-groups-(nitags)."},{"key":"10.1016\/j.vaccine.2025.127876_bb0115","series-title":"ACIP Charter. Advisory Committee on Immunization Practices (ACIP)","year":"2024"},{"issue":"10","key":"10.1016\/j.vaccine.2025.127876_bb0120","first-page":"258","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"RR-04","key":"10.1016\/j.vaccine.2025.127876_bb0125","first-page":"1","article-title":"Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"McLean","year":"2013","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127876_bb0130","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2010-0665","article-title":"Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures","volume":"126","author":"Klein","year":"2010","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127876_bb0135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.292.3.351","article-title":"MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis","volume":"292","author":"Vestergaard","year":"2004","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127876_bb0140","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1542\/peds.2014-1822","article-title":"Safety of measles-containing vaccines in 1-year-old children","volume":"135","author":"Klein","year":"2015","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127876_bb0155","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1503\/cmaj.140078","article-title":"Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study","volume":"186","author":"MacDonald","year":"2014","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127876_bb0160","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1542\/peds.2008-0939","article-title":"Febrile seizures: clinical practice guideline for the long-term management of the child with simple febrile seizures","volume":"121","author":"AAP","year":"2008","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.vaccine.2025.127876_bb0165","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1542\/peds.2011-3198","article-title":"Measles-containing vaccines and febrile seizures in children age 4 to 6 years","volume":"129","author":"Klein","year":"2012","journal-title":"Pediatrics"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127876_bb0170","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.vaccine.2022.02.072","article-title":"Second dose of measles-mumps-rubella-varicella vaccine (MMRV) and the risk of febrile convulsions","volume":"40","author":"Sch\u00e4fer","year":"2022","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2025.127876_bb0175","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.292.3.351","article-title":"MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis","volume":"292","author":"Vestergaard","year":"2004","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.vaccine.2025.127876_bb0190","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s11606-020-06456-z","article-title":"Shared clinical decision-making recommendations for adult immunization: what do physicians think?","volume":"36","author":"Kempe","year":"2021","journal-title":"J Gen Intern Med"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127876_bb0195","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.inf.0000145700.77286.94","article-title":"Hepatitis B vaccination associated with higher female than male mortality in Guinea-Bissau: an observational study","volume":"23","author":"Garly","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127876_bb0205","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","article-title":"Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state","volume":"151","author":"McMahon","year":"1985","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2025.127876_bb0210","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/hep.32474","article-title":"Protection and antibody levels 35 years after primary series with hepatitis B vaccine and response to a booster dose","volume":"76","author":"Bruce","year":"2022","journal-title":"Hepatol Baltim Md"},{"issue":"6","key":"10.1016\/j.vaccine.2025.127876_bb0215","doi-asserted-by":"crossref","first-page":"e1500","DOI":"10.1542\/peds.2013-2940","article-title":"Duration of protection after infant hepatitis B vaccination series","volume":"133","author":"Middleman","year":"2014","journal-title":"Pediatrics"},{"issue":"19","key":"10.1016\/j.vaccine.2025.127876_bb0220","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM198911093211905","article-title":"Hepatitis B virus infection among children born in the United States to southeast Asian refugees","volume":"321","author":"Franks","year":"1989","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127876_bb0225","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1542\/peds.89.2.269","article-title":"Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees","volume":"89","author":"Hurie","year":"1992","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127876_bb0230","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-055554","article-title":"Risks of infectious diseases in newborns exposed to alternative perinatal practices","volume":"149","author":"Nolt","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2025.127876_bb0250","article-title":"Updates to COVID-19 epidemiology","year":"2025","journal-title":"ACIP Meeting"},{"issue":"14","key":"10.1016\/j.vaccine.2025.127876_bb0260","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127876_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.02.065","article-title":"Overview of U.S. COVID-19 vaccine safety surveillance systems","volume":"42","author":"Gee","year":"2024","journal-title":"Vaccine"},{"issue":"30","key":"10.1016\/j.vaccine.2025.127876_bb0270","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1016\/j.vaccine.2023.06.023","article-title":"Post-authorization safety surveillance of ad.26.COV2.S vaccine: reports to the vaccine adverse event reporting system and v-safe, February 2021-February 2022","volume":"41","author":"Woo","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127876_bb0280","author":"Shimabukuro"},{"key":"10.1016\/j.vaccine.2025.127876_bb0285","doi-asserted-by":"crossref","DOI":"10.2196\/53807","article-title":"Ischemic stroke after bivalent COVID-19 vaccination: self-controlled case series study","volume":"10","author":"Xu","year":"2024","journal-title":"JMIR Public Health Surveill"},{"issue":"11","key":"10.1016\/j.vaccine.2025.127876_bb0290","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jama.2024.1059","article-title":"Stroke risk after COVID-19 bivalent vaccination among US older adults","volume":"331","author":"Lu","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.127876_bb0295","author":"Levi"},{"key":"10.1016\/j.vaccine.2025.127876_bb0300","article-title":"Additional workgroup considerations in COVID-19 vaccination policy and practice","author":"Perlman","year":"2025","journal-title":"ACIP Meeting"},{"key":"10.1016\/j.vaccine.2025.127876_bb0305","article-title":"Economic analysis of COVID-19 vaccination","author":"Srinivasan","year":"2025","journal-title":"ACIP Meeting"},{"key":"10.1016\/j.vaccine.2025.127876_bb0310","article-title":"COVID-19 vaccine safety surveillance: summary from VSD RCA","author":"Klein","year":"2023","journal-title":"ACIP Meeting"},{"issue":"2","key":"10.1016\/j.vaccine.2025.127876_bb0315","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-057313","article-title":"Safety of COVID-19 vaccination in United States children ages 5 to 11 years","volume":"150","author":"Hause","year":"2022","journal-title":"Pediatrics"},{"issue":"35","key":"10.1016\/j.vaccine.2025.127876_bb0320","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1016\/j.vaccine.2022.07.007","article-title":"Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination","volume":"40","author":"Goddard","year":"2022","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2025.127876_bb0325","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.7326\/M22-2274","article-title":"Incidence of myocarditis\/pericarditis following mRNA COVID-19 vaccination among children and younger adults in the United States","volume":"175","author":"Goddard","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2025.127876_bb0330","first-page":"96","article-title":"Biodistribution of mRNA COVID-19 vaccines in human breast milk","author":"Hanna","year":"2023","journal-title":"eBioMedicine"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127876_bb0335","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac581","article-title":"RNAdegformer: accurate prediction of mRNA degradation at nucleotide resolution with deep learning","volume":"24","author":"He","year":"2023","journal-title":"Brief Bioinform"},{"issue":"1","key":"10.1016\/j.vaccine.2025.127876_bb0340","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13059-022-02811-x","article-title":"The genetic and biochemical determinants of mRNA degradation rates in mammals","volume":"23","author":"Agarwal","year":"2022","journal-title":"Genome Biol"},{"key":"10.1016\/j.vaccine.2025.127876_bb0345","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1153624","article-title":"Regulation of eukaryotic mRNA deadenylation and degradation by the Ccr4-not complex","volume":"11","author":"Pavanello","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.vaccine.2025.127876_bb0350","author":"CDC"},{"key":"10.1016\/j.vaccine.2025.127876_bb0355","author":"CDC"},{"key":"10.1016\/j.vaccine.2025.127876_bb0360","author":"KFF"},{"key":"10.1016\/j.vaccine.2025.127876_bb0365","author":"KFF"},{"key":"10.1016\/j.vaccine.2025.127876_bb0370","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-025-03054-z","article-title":"Hotly anticipated US vaccine meeting ends with confusion \u2014 and a few decisions","author":"Lenharo","year":"2025","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25011739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25011739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T20:28:34Z","timestamp":1763324914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25011739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":58,"alternative-id":["S0264410X25011739"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127876","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Science for vaccine policy: Independent review of the September 2025 ACIP processes, deliberations and votes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"127876"}}